AMPLIFYBIO
AmplifyBio is a biotechnology company that develops next-generation cell and gene therapies. The company's mission is to create pathways for novel treatment advances, cutting-edge technologies, and new research frontiers to advance medical breakthroughs, treatments, and cures for disease. AmplifyBio was founded in 2021 and is headquartered in West Jefferson, OH.
AMPLIFYBIO
Industry:
Biotechnology Health Care Life Science
Founded:
2021-01-01
Address:
West Jefferson, Ohio, United States
Country:
United States
Website Url:
http://www.amplify-bio.com
Total Employee:
251+
Status:
Active
Contact:
833-641-2006
Email Addresses:
[email protected]
Total Funding:
279.75 M USD
Technology used in webpage:
Domain Not Resolving Amazon Person Schema Office 365 Mail Gravatar Profiles Amazon Virginia Region Unified Layer BlueHost
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-10-03 | PACT Pharma - Assets | PACT Pharma - Assets acquired by AmplifyBio | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - AmplifyBio
Viking Capital
Viking Capital investment in Venture Round - AmplifyBio
Narya Capital
Narya Capital investment in Venture Round - AmplifyBio
Battelle
Battelle investment in Venture Round - AmplifyBio
Official Site Inspections
http://www.amplify-bio.com Semrush global rank: 4.18 M Semrush visits lastest month: 2.42 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AmplifyBio"
AmplifyBio - Advanced Therapy CDMO
Jul 30, 2024 AmplifyBio is a concept to commercial CRO dedicated to providing expert services for drug discovery, characterization, optimization, in vitro and in vivo safety studies, and manufacturing for a broad range of drug modalities, …See details»
AmplifyBio - Crunchbase Company Profile & Funding
Organization. AmplifyBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; Phone Number 833-641-2006; AmplifyBio is …See details»
Preclinical CRO Services - AmplifyBio
Contract Research Organization Services Whether you’re developing a traditional small molecule drug or advanced therapies, AmplifyBio is a preclinical CRO with the experience and capabilities to guide you through a single study or a full …See details»
AmplifyBio Company Profile 2024: Valuation, Funding …
AmplifyBio General Information Description. Operator of a biotechnology platform intended to advance the quality of human health and save lives. The company's platform focuses on research and development to develop vaccine …See details»
AmplifyBio Expands Its Vision: Launches Advanced Therapy
NEW ALBANY, Ohio, November 28, 2023 (Newswire.com) - AmplifyBio, a leading contract research organization, is announcing the opening of a new business unit to further expand its …See details»
AmplifyBio - Products, Competitors, Financials, Employees, …
AmplifyBio is a contract research and manufacturing organization founded on the principle that the development and scale-up of advanced modality drugs should be done with commercial and …See details»
AMPLIFYBIO ACQUIRES PACT PHARMA ASSETS TO …
Oct 3, 2022 AmplifyBio was spun out in 2021 from Battelle, a not-for-profit organization that advances science and technology to have the greatest impact on our society and economy.See details»
Media Room of AmplifyBio
News Apr 16, 2024 AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture . AmplifyBio, a Contract …See details»
AmplifyBio Expands Its Vision: Launches Advanced Therapy …
Nov 28, 2023 The Amplify Manufacturing Enablement Center (AMEC), located… NEW ALBANY, Ohio, November 28, 2023 (Newswire.com) – AmplifyBio, a leading contract research …See details»
AmplifyBio and RNAV8 Bio Announce Strategic …
Apr 16, 2024 About Amplify Bio: AmplifyBio is a contract research and manufacturing organization founded on the principle that all development and scale-up of advanced modality drugs should be done with ...See details»
AmplifyBio Celebrates One Year Since Launch With an Expansion …
Jul 12, 2022 A preclinical CRO built for the future on a foundation of experience: amplify-bio.com Featured Image for AmplifyBio Featured Image for AmplifyBio WEST JEFFERSON, Ohio, July …See details»
AmplifyBio Celebrates One Year Since Launch With an
WEST JEFFERSON, Ohio, July 12, 2022 (GLOBE NEWSWIRE) -- AmplifyBio spent the month of June commemorating the first anniversary since its spin-off from the Battelle organization. The …See details»
AmplifyBio Emerges as a Leader in Cell Therapy Characterization ...
Mar 16, 2023 AmplifyBio's South San Francisco site, branded A-DOC (Amplify - Discovery, Optimization, and Characterization), is already partnering with several clients developing cell …See details»
AmplifyBio Latest News | AmplifyBio
May 20, 2024 AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture AmplifyBio, a Contract …See details»
AmplifyBio Expands Its Vision: Launches Advanced Therapy …
NEW ALBANY, Ohio, November 28, 2023 (Newswire.com) - AmplifyBio, a leading contract research organization, is announcing the opening of a new business unit to further expand its …See details»
AmplifyBio and Xcell Biosciences Announce Partnership to …
May 20, 2024 SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif., May 20, 2024--Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene …See details»
AmplifyBio and RNAV8 Bio Form Strategic Partnership to Assist …
Apr 17, 2024 AmplifyBio, a Contract Development and Manufacturing Organization and Contract Research Organization, and RNAV8 Bio, a rising startup specializing in mRNA engineering …See details»
Cell & Gene Advanced Therapy Discovery Services - AmplifyBio
We apply this experience across business units to offer cell therapy R&D services, including everything from preclinical research to clinical-grade production. Our contract research …See details»
AmplifyBio Emerges as a Leader in Cell Therapy ... - Newswire
Mar 16, 2023 [email protected] 904-738-5897 More Press Releases AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery CapabilitiesSee details»